Expertise in
3
conditions

Sara Bringhen

Citta, IT 
Expertise in
3
conditions
Citta, IT 

Overview

Sara Bringhen practices practicing medicine in Citta, Italy.

Ms. Bringhen is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Hypertension, Smoldering Multiple Myeloma, and Bone Marrow Transplant.

She is actively involved in clinical research, co-authoring 129 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Citta, Italy
Other Locations
Cuneo, Italy
Turin, Italy
Florence, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3 Randomized, Controlled, Open-label Study of Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
A Phase 3 Randomized, Controlled, Open-label Study of Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
Enrollment Status: Completed
Publish Date: August 21, 2024
Intervention Type: Drug
Study Drugs: Selinexor, Bortezomib, Dexamethasone
Study Phase: Phase 3

129 Total Publications

Plain language summary of a study on 30-minute intravenous infusion of isatuximab in people with newly diagnosed multiple myeloma.
Plain language summary of a study on 30-minute intravenous infusion of isatuximab in people with newly diagnosed multiple myeloma.
Journal: Future oncology (London, England)
Published: April 27, 2026

Frequently Asked Questions about Sara Bringhen

Is Sara Bringhen a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Sara Bringhen is classified as an Elite expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sara Bringhen participate in research or clinical trials?

Yes. Sara Bringhen has published 129 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Sara Bringhen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Bringhen's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile